GLP-1 medications reduce overall food intake, and many patients naturally reduce refined carbohydrate consumption as appetite suppression shifts food preferences toward higher-protein, lower-sugar options
2 Compounded semaglutide is administered as a once-weekly subcutaneous injection in the abdomen, thigh, or upper arm
Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials
In practical terms, the receptors on any given cell begin losing sensitivity within minutes of sustained agonist exposure
More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/2026 1 , while around 2.5 million people each month accessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of the Digital Clinical Excellence (DiCE) network of primary care digital health providers
3 GLP-1R localization and mechanistic pathways in metabolic and behavioral regulation GLP-1 Rs exhibit high expression in pancreatic -cells in both rodents and humans, where they play a pivotal role in mediating glucose-dependent insulin secretion (Nauck et al., 1993
